How Mylan Turned EpiPen Into a Must-Have

Mylan purchased the EpiPen brand from Merck KGaA in 2007 and proceeded to build the brand into a billion-dollar business. Bloomberg's Cynthia Koons explains how Mylan turned EpiPen into a hit. She speaks on "Bloomberg Markets." (Source: Bloomberg)

Analyst Epstein Sees No Bulls, but a Bounce for Oil
17:20 - In today's "Futures in Focus," Ira Epstein, senior market analyst at Ira Epstein Division of Linn & Associates, and Bloomberg's Vonnie Barton examine oil market fluctuations as prices remain low amid peak demand. They speak on "Bloomberg Markets." (Source: Bloomberg)
  • Schork Says EIA Crude Build Is a 'Push' for Market
  • Carney Says BOE May Need to Start Raising Rates Soon
  • Draghi Says Monetary Policy Should Not Be Overburdened